PIQ proteomics international laboratories ltd

Ann: Annual Report to shareholders, page-5

  1. 13,513 Posts.
    lightbulb Created with Sketch. 7311
    Very Solid small company,


    The Group's financial report for the year ended 30 June 2018 includes:


    • Operating revenue from services continued its upward trend reaching $1,176,457, a 27% increase compared tothe previous year.


    • Combined income from all sources rose 16% to $2.15 million. Revenue from ordinary activities encapsulatesincome from the Company's analytical services, licensing fees, and grant income including the R&D TaxIncentive.


    • Operational expenditure totalled $3.59 million, an increase of 29% in-line with budget, and reflecting anincrease in activity in the commercialisation of PromarkerD and the launch of new analytical services.


    • The loss from ordinary activities is $1.44million, which represents a year on year increase of 57%.


    • At 30 June 2018 the Company had cash reserves of $2.5 million. On the back of the Company's research anddevelopment focus it anticipates an R&D Tax Incentive cash rebate of $844,123, to be received in the Decemberquarter. 


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
0.000(0.00%)
Mkt cap ! $47.42M
Open High Low Value Volume
30.5¢ 30.5¢ 28.5¢ $187.1K 634.3K

Buyers (Bids)

No. Vol. Price($)
8 81754 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 1000 1
View Market Depth
Last trade - 15.57pm 27/06/2025 (20 minute delay) ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.